Aclaris Therapeutics ACRS Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Aclaris Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Aclaris Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aclaris Therapeutics's other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aclaris Therapeutics's other non-current assets?
- Aclaris Therapeutics (ACRS) reported other non-current assets of $2.37M in Q1 2026.
- How has Aclaris Therapeutics's other non-current assets changed year-over-year?
- Aclaris Therapeutics's other non-current assets decreased by 24.8% year-over-year, from $3.15M to $2.37M.
- What is the long-term trend for Aclaris Therapeutics's other non-current assets?
- Over 5 years (2020 to 2025), Aclaris Therapeutics's other non-current assets has grown at a -9.3% compound annual growth rate (CAGR), from $4.51M to $2.77M.
- What does other non-current assets mean?
- This category captures long-term assets that do not fit into standard classifications like property, plant, equipment, or intangible assets. It may include long-term deposits, deferred tax assets, or other miscellaneous non-current investments. It represents the residual value of long-term resources held by the company.